S 854 · 119th Congress · Health

Risky Research Review Act

Introduced 2025-03-05· Sponsored by Sen. Paul, Rand [R-KY]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.(2025-09-17)

Plain Language Summary

[AI summary unavailable — showing source text] Risky Research Review Act This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research.  High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola). Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review.  In making its determinations, the board must consider specified factors, including whether the benefits of the resea…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

S. 854, Risky Research Review Act

Aug 20, 2025

As ordered reported by the Senate Committee on Homeland Security and Governmental Affairs on July 30, 2025

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (1)

1 Democrat